دورية أكاديمية

A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAPLACIZUMAB WITHOUT FIRST-LINE THERAPEUTIC PLASMA EXCHANGE IN ADULTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA

التفاصيل البيبلوغرافية
العنوان: A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAPLACIZUMAB WITHOUT FIRST-LINE THERAPEUTIC PLASMA EXCHANGE IN ADULTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
المؤلفون: GUNAWARDENA, Sriya, HU, Angela, MENAPACE, Laurel A., OKADA, Hikaru, ACCOMANDO, Beverly, LIN, Julie
المصدر: Hematology, Transfusion and Cell Therapy ; volume 45, page S38-S39 ; ISSN 2531-1379
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Hematology, Immunology and Allergy
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.htct.2023.09.066
الإتاحة: https://doi.org/10.1016/j.htct.2023.09.066Test
https://api.elsevier.com/content/article/PII:S2531137923002420?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2531137923002420?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.A41DB6B6
قاعدة البيانات: BASE